Rani Therapeutics Holdings Inc
NASDAQ:RANI
Rani Therapeutics Holdings Inc
NASDAQ:RANI
Price:
1.37
USD
Market Closed
Market Cap:
$166.5m
Income Statement
Earnings Waterfall
Rani Therapeutics Holdings Inc
Rani Therapeutics Holdings Inc
Income Statement
Rani Therapeutics Holdings Inc
Rani Therapeutics Holdings Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
4
|
4
|
|
| Revenue |
0
N/A
|
1
+148%
|
3
+167%
|
3
-4%
|
3
-7%
|
2
-28%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
+17%
|
1
N/A
|
1
N/A
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(17)
|
(17)
|
(21)
|
(46)
|
(54)
|
(63)
|
(71)
|
(59)
|
(63)
|
(66)
|
(69)
|
(70)
|
(66)
|
(64)
|
(58)
|
(52)
|
(51)
|
(52)
|
(50)
|
(46)
|
|
| Selling, General & Administrative |
(5)
|
(6)
|
(9)
|
(24)
|
(28)
|
(31)
|
(34)
|
(26)
|
(27)
|
(27)
|
(28)
|
(28)
|
(26)
|
(26)
|
(25)
|
(24)
|
(24)
|
(23)
|
(22)
|
(19)
|
|
| Research & Development |
(12)
|
(11)
|
(13)
|
(22)
|
(26)
|
(31)
|
(37)
|
(34)
|
(37)
|
(39)
|
(40)
|
(42)
|
(40)
|
(38)
|
(33)
|
(27)
|
(27)
|
(26)
|
(25)
|
(23)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(4)
|
(4)
|
|
| Operating Income |
(17)
N/A
|
(16)
+1%
|
(18)
-11%
|
(43)
-137%
|
(52)
-19%
|
(61)
-18%
|
(71)
-17%
|
(59)
+17%
|
(63)
-7%
|
(66)
-4%
|
(69)
-4%
|
(70)
-2%
|
(66)
+6%
|
(64)
+4%
|
(58)
+9%
|
(52)
+10%
|
(50)
+4%
|
(51)
-3%
|
(49)
+4%
|
(45)
+9%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(17)
N/A
|
(17)
-1%
|
(20)
-16%
|
(45)
-131%
|
(53)
-17%
|
(61)
-15%
|
(72)
-17%
|
(59)
+17%
|
(63)
-7%
|
(66)
-5%
|
(69)
-4%
|
(71)
-3%
|
(68)
+5%
|
(66)
+3%
|
(61)
+8%
|
(55)
+9%
|
(57)
-3%
|
(55)
+4%
|
(52)
+4%
|
(48)
+9%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(17)
|
(17)
|
(20)
|
(46)
|
(53)
|
(61)
|
(72)
|
(59)
|
(63)
|
(66)
|
(69)
|
(71)
|
(68)
|
(66)
|
(61)
|
(55)
|
(57)
|
(55)
|
(52)
|
(48)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
26
|
45
|
41
|
50
|
32
|
33
|
34
|
35
|
36
|
34
|
33
|
30
|
27
|
27
|
25
|
23
|
19
|
|
| Net Income (Common) |
(17)
N/A
|
(17)
-1%
|
(9)
+49%
|
(9)
-3%
|
(8)
+6%
|
(9)
-7%
|
(22)
-148%
|
(27)
-22%
|
(31)
-13%
|
(33)
-7%
|
(34)
-5%
|
(36)
-4%
|
(34)
+5%
|
(33)
+3%
|
(31)
+8%
|
(28)
+8%
|
(30)
-7%
|
(30)
+1%
|
(30)
+0%
|
(28)
+5%
|
|
| EPS (Diluted) |
-0.35
N/A
|
-0.37
-6%
|
-0.19
+49%
|
-0.45
-137%
|
-0.43
+4%
|
-0.41
+5%
|
-0.9
-120%
|
-1.1
-22%
|
-1.28
-16%
|
-1.29
-1%
|
-1.35
-5%
|
-1.41
-4%
|
-1.33
+6%
|
-1.27
+5%
|
-1.18
+7%
|
-0.97
+18%
|
-1.05
-8%
|
-0.89
+15%
|
-0.81
+9%
|
-0.6
+26%
|
|
Switch to:
Switch to:
See Also
Discover More
